Toll Free: 1-888-928-9744
Published: Feb, 2017 | Pages:
120 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Notes: Sales, means the sales volume of PDE Inhibitors Revenue, means the sales value of PDE Inhibitors This report studies sales (consumption) of PDE Inhibitors in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Hanmi Science Holding Boehringer Ingelheim Takeda Pharmaceuticals Pfizer Omeros Corporation Anacor Pharmaceuticals Otsuka Chiesi Farmaceutici Verona Pharma NuSirt Biopharma Market Segment by States, covering California Texas New York Florida Illinois Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into PDE5 PDE4 Viagra? Cialis? Levitra Others Split by applications, this report focuses on sales, market share and growth rate of PDE Inhibitors in each application, can be divided into GENITOURINARY CARDIOVASCULAR DISEASES NEUROLOGICAL DISEASES DERMATOLOGICAL DISORDERS RESPIRATORY DISEASES OTHER INDICATIONS
Table of Contents United States PDE Inhibitors Market Report 2017 1 PDE Inhibitors Overview 1.1 Product Overview and Scope of PDE Inhibitors 1.2 Classification of PDE Inhibitors 1.2.1 PDE5 1.2.2 PDE4 1.2.3 Viagra? 1.2.4 Cialis? 1.2.5 Levitra 1.2.6 Others 1.3 Application of PDE Inhibitors 1.3.1 GENITOURINARY 1.3.2 CARDIOVASCULAR DISEASES 1.3.3 NEUROLOGICAL DISEASES 1.3.4 DERMATOLOGICAL DISORDERS 1.3.5 RESPIRATORY DISEASES 1.3.6 OTHER INDICATIONS 1.4 United States Market Size Sales (Volume) and Revenue (Value) of PDE Inhibitors (2012-2022) 1.4.1 United States PDE Inhibitors Sales and Growth Rate (2012-2022) 1.4.2 United States PDE Inhibitors Revenue and Growth Rate (2012-2022) 2 United States PDE Inhibitors Competition by Manufacturers 2.1 United States PDE Inhibitors Sales and Market Share of Key Manufacturers (2015 and 2016) 2.2 United States PDE Inhibitors Revenue and Share by Manufactures (2015 and 2016) 2.3 United States PDE Inhibitors Average Price by Manufactures (2015 and 2016) 2.4 PDE Inhibitors Market Competitive Situation and Trends 2.4.1 PDE Inhibitors Market Concentration Rate 2.4.2 PDE Inhibitors Market Share of Top 3 and Top 5 Manufacturers 2.4.3 Mergers & Acquisitions, Expansion 3 United States PDE Inhibitors Sales (Volume) and Revenue (Value) by States (2012-2017) 3.1 United States PDE Inhibitors Sales and Market Share by States (2012-2017) 3.2 United States PDE Inhibitors Revenue and Market Share by States (2012-2017) 3.3 United States PDE Inhibitors Price by States (2012-2017) 4 United States PDE Inhibitors Sales (Volume) and Revenue (Value) by Type (2012-2017) 4.1 United States PDE Inhibitors Sales and Market Share by Type (2012-2017) 4.2 United States PDE Inhibitors Revenue and Market Share by Type (2012-2017) 4.3 United States PDE Inhibitors Price by Type (2012-2017) 4.4 United States PDE Inhibitors Sales Growth Rate by Type (2012-2017) 5 United States PDE Inhibitors Sales (Volume) by Application (2012-2017) 5.1 United States PDE Inhibitors Sales and Market Share by Application (2012-2017) 5.2 United States PDE Inhibitors Sales Growth Rate by Application (2012-2017) 5.3 Market Drivers and Opportunities 6 United States PDE Inhibitors Manufacturers Profiles/Analysis 6.1 Hanmi Science Holding 6.1.1 Company Basic Information, Manufacturing Base and Competitors 6.1.2 PDE Inhibitors Product Type, Application and Specification 6.1.2.1 PDE5 6.1.2.2 PDE4 6.1.3 Hanmi Science Holding PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) 6.1.4 Main Business/Business Overview 6.2 Boehringer Ingelheim 6.2.2 PDE Inhibitors Product Type, Application and Specification 6.2.2.1 PDE5 6.2.2.2 PDE4 6.2.3 Boehringer Ingelheim PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) 6.2.4 Main Business/Business Overview 6.3 Takeda Pharmaceuticals 6.3.2 PDE Inhibitors Product Type, Application and Specification 6.3.2.1 PDE5 6.3.2.2 PDE4 6.3.3 Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) 6.3.4 Main Business/Business Overview 6.4 Pfizer 6.4.2 PDE Inhibitors Product Type, Application and Specification 6.4.2.1 PDE5 6.4.2.2 PDE4 6.4.3 Pfizer PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) 6.4.4 Main Business/Business Overview 6.5 Omeros Corporation 6.5.2 PDE Inhibitors Product Type, Application and Specification 6.5.2.1 PDE5 6.5.2.2 PDE4 6.5.3 Omeros Corporation PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) 6.5.4 Main Business/Business Overview 6.6 Anacor Pharmaceuticals 6.6.2 PDE Inhibitors Product Type, Application and Specification 6.6.2.1 PDE5 6.6.2.2 PDE4 6.6.3 Anacor Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) 6.6.4 Main Business/Business Overview 6.7 Otsuka 6.7.2 PDE Inhibitors Product Type, Application and Specification 6.7.2.1 PDE5 6.7.2.2 PDE4 6.7.3 Otsuka PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) 6.7.4 Main Business/Business Overview 6.8 Chiesi Farmaceutici 6.8.2 PDE Inhibitors Product Type, Application and Specification 6.8.2.1 PDE5 6.8.2.2 PDE4 6.8.3 Chiesi Farmaceutici PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) 6.8.4 Main Business/Business Overview 6.9 Verona Pharma 6.9.2 PDE Inhibitors Product Type, Application and Specification 6.9.2.1 PDE5 6.9.2.2 PDE4 6.9.3 Verona Pharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) 6.9.4 Main Business/Business Overview 6.10 NuSirt Biopharma 6.10.2 PDE Inhibitors Product Type, Application and Specification 6.10.2.1 PDE5 6.10.2.2 PDE4 6.10.3 NuSirt Biopharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) 6.10.4 Main Business/Business Overview 7 PDE Inhibitors Manufacturing Cost Analysis 7.1 PDE Inhibitors Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Price Trend of Key Raw Materials 7.1.3 Key Suppliers of Raw Materials 7.1.4 Market Concentration Rate of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.2.1 Raw Materials 7.2.2 Labor Cost 7.2.3 Manufacturing Expenses 7.3 Manufacturing Process Analysis of PDE Inhibitors 8 Industrial Chain, Sourcing Strategy and Downstream Buyers 8.1 PDE Inhibitors Industrial Chain Analysis 8.2 Upstream Raw Materials Sourcing 8.3 Raw Materials Sources of PDE Inhibitors Major Manufacturers in 2015 8.4 Downstream Buyers 9 Marketing Strategy Analysis, Distributors/Traders 9.1 Marketing Channel 9.1.1 Direct Marketing 9.1.2 Indirect Marketing 9.1.3 Marketing Channel Development Trend 9.2 Market Positioning 9.2.1 Pricing Strategy 9.2.2 Brand Strategy 9.2.3 Target Client 9.3 Distributors/Traders List 10 Market Effect Factors Analysis 10.1 Technology Progress/Risk 10.1.1 Substitutes Threat 10.1.2 Technology Progress in Related Industry 10.2 Consumer Needs/Customer Preference Change 10.3 Economic/Political Environmental Change 11 United States PDE Inhibitors Market Forecast (2017-2022) 11.1 United States PDE Inhibitors Sales, Revenue Forecast (2017-2022) 11.2 United States PDE Inhibitors Sales Forecast by Type (2017-2022) 11.3 United States PDE Inhibitors Sales Forecast by Application (2017-2022) 11.4 PDE Inhibitors Price Forecast (2017-2022) 12 Research Findings and Conclusion 13 Appendix Methodology Analyst Introduction Data Source
List of Tables and Figures Figure Picture of PDE Inhibitors Table Classification of PDE Inhibitors Figure United States Sales Market Share of PDE Inhibitors by Type in 2015 Figure PDE5 Picture Figure PDE4 Picture Figure Viagra? Picture Figure Cialis? Picture Figure Levitra Picture Figure Others Picture Table Application of PDE Inhibitors Figure United States Sales Market Share of PDE Inhibitors by Application in 2015 Figure GENITOURINARY Examples Figure CARDIOVASCULAR DISEASES Examples Figure NEUROLOGICAL DISEASES Examples Figure DERMATOLOGICAL DISORDERS Examples Figure RESPIRATORY DISEASES Examples Figure OTHER INDICATIONS Examples Figure United States PDE Inhibitors Sales and Growth Rate (2012-2022) Figure United States PDE Inhibitors Revenue and Growth Rate (2012-2022) Table United States PDE Inhibitors Sales of Key Manufacturers (2015 and 2016) Table United States PDE Inhibitors Sales Share by Manufacturers (2015 and 2016) Figure 2015 PDE Inhibitors Sales Share by Manufacturers Figure 2016 PDE Inhibitors Sales Share by Manufacturers Table United States PDE Inhibitors Revenue by Manufacturers (2015 and 2016) Table United States PDE Inhibitors Revenue Share by Manufacturers (2015 and 2016) Table 2015 United States PDE Inhibitors Revenue Share by Manufacturers Table 2016 United States PDE Inhibitors Revenue Share by Manufacturers Table United States Market PDE Inhibitors Average Price of Key Manufacturers (2015 and 2016) Figure United States Market PDE Inhibitors Average Price of Key Manufacturers in 2015 Figure PDE Inhibitors Market Share of Top 3 Manufacturers Figure PDE Inhibitors Market Share of Top 5 Manufacturers Table United States PDE Inhibitors Sales by States (2012-2017) Table United States PDE Inhibitors Sales Share by States (2012-2017) Figure United States PDE Inhibitors Sales Market Share by States in 2015 Table United States PDE Inhibitors Revenue and Market Share by States (2012-2017) Table United States PDE Inhibitors Revenue Share by States (2012-2017) Figure Revenue Market Share of PDE Inhibitors by States (2012-2017) Table United States PDE Inhibitors Price by States (2012-2017) Table United States PDE Inhibitors Sales by Type (2012-2017) Table United States PDE Inhibitors Sales Share by Type (2012-2017) Figure United States PDE Inhibitors Sales Market Share by Type in 2015 Table United States PDE Inhibitors Revenue and Market Share by Type (2012-2017) Table United States PDE Inhibitors Revenue Share by Type (2012-2017) Figure Revenue Market Share of PDE Inhibitors by Type (2012-2017) Table United States PDE Inhibitors Price by Type (2012-2017) Figure United States PDE Inhibitors Sales Growth Rate by Type (2012-2017) Table United States PDE Inhibitors Sales by Application (2012-2017) Table United States PDE Inhibitors Sales Market Share by Application (2012-2017) Figure United States PDE Inhibitors Sales Market Share by Application in 2015 Table United States PDE Inhibitors Sales Growth Rate by Application (2012-2017) Figure United States PDE Inhibitors Sales Growth Rate by Application (2012-2017) Table Hanmi Science Holding Basic Information List Table Hanmi Science Holding PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) Figure Hanmi Science Holding PDE Inhibitors Sales Market Share (2012-2017) Table Boehringer Ingelheim Basic Information List Table Boehringer Ingelheim PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) Table Boehringer Ingelheim PDE Inhibitors Sales Market Share (2012-2017) Table Takeda Pharmaceuticals Basic Information List Table Takeda Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) Table Takeda Pharmaceuticals PDE Inhibitors Sales Market Share (2012-2017) Table Pfizer Basic Information List Table Pfizer PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) Table Pfizer PDE Inhibitors Sales Market Share (2012-2017) Table Omeros Corporation Basic Information List Table Omeros Corporation PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) Table Omeros Corporation PDE Inhibitors Sales Market Share (2012-2017) Table Anacor Pharmaceuticals Basic Information List Table Anacor Pharmaceuticals PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) Table Anacor Pharmaceuticals PDE Inhibitors Sales Market Share (2012-2017) Table Otsuka Basic Information List Table Otsuka PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) Table Otsuka PDE Inhibitors Sales Market Share (2012-2017) Table Chiesi Farmaceutici Basic Information List Table Chiesi Farmaceutici PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) Table Chiesi Farmaceutici PDE Inhibitors Sales Market Share (2012-2017) Table Verona Pharma Basic Information List Table Verona Pharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) Table Verona Pharma PDE Inhibitors Sales Market Share (2012-2017) Table NuSirt Biopharma Basic Information List Table NuSirt Biopharma PDE Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017) Table NuSirt Biopharma PDE Inhibitors Sales Market Share (2012-2017) Table Production Base and Market Concentration Rate of Raw Material Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of PDE Inhibitors Figure Manufacturing Process Analysis of PDE Inhibitors Figure PDE Inhibitors Industrial Chain Analysis Table Raw Materials Sources of PDE Inhibitors Major Manufacturers in 2015 Table Major Buyers of PDE Inhibitors Table Distributors/Traders List Figure United States PDE Inhibitors Production and Growth Rate Forecast (2017-2022) Figure United States PDE Inhibitors Revenue and Growth Rate Forecast (2017-2022) Table United States PDE Inhibitors Production Forecast by Type (2017-2022) Table United States PDE Inhibitors Consumption Forecast by Application (2017-2022) Table United States PDE Inhibitors Sales Forecast by States (2017-2022) Table United States PDE Inhibitors Sales Share Forecast by States (2017-2022)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.